首页> 美国卫生研究院文献>Case Reports in Gastroenterology >Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
【2h】

Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis

机译:一名29岁男性无原发性硬化性胆管炎的切除晚期肝门胆管癌的免疫组织化学检查。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the entire thickness of the hepatic duct and the adjacent liver tissue (T3) and which was associated with lymph node metastasis (N1). It was a stage IIB (T3N1M0) tubular adenocarcinoma according to UICC pathological staging. Immunohistochemical examination revealed that Ki-67, cyclin D1, and MMP-7 were positive, and 14-3-3σ and p27 were negative. The pathological and immunohistochemical findings indicated high malignant potential indicating poor prognosis. We administrated the postoperative adjunct gemcitabine combined with S-1 chemotherapy. The patient is alive without recurrence and doing well two years after surgery. We also review other reports of cholangiocarcinoma patients aged less than 30 years.
机译:一名患有晚期肝门胆管癌的29岁男子已成功通过扩展右叶切除术治疗。碳水化合物抗原19-9(CA19-9)的水平升高至939 IU / l,病理结果显示中度分化的肾小管腺癌几乎累及了整个肝管和相邻肝组织(T3)的厚度,与淋巴结转移有关(N1)。根据UICC病理分期,它是IIB期(T3N1M0)管状腺癌。免疫组织化学检查显示Ki-67,cyclin D1和MMP-7为阳性,而14-3-3σ和p27为阴性。病理和免疫组化结果提示恶性潜能高,预后不良。我们给予术后辅助吉西他滨联合S-1化疗。病人还活着,没有复发,手术两年后状况良好。我们还回顾了年龄小于30岁的胆管癌患者的其他报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号